Stacey Ann N. D’mello

Evidence that phospholipase C is involved in the antitumour action of NSC768313, a new thieno[2,3-b]pyridine derivative

Jóhannes Reynisson, Jagdish K. Jaiswal, David Barker et al. · Cancer Cell International · 2016 · 35 citations · Full text

Evidence That GRIN2A Mutations in Melanoma Correlate with Decreased Survival

Stacey Ann N. D’mello, Jack U. Flanagan, Taryn N. Green et al. · Frontiers in Oncology · 2014 · 26 citations · Full text

Combination of bemcentinib (BGB324): A first-in-class selective oral AXL inhibitor, with pembrolizumab in patients with triple negative breast cancer and adenocarcinoma of the lung.

Murray Yule, Kjersti Davidsen, Magnus Bloe et al. · Journal of Clinical Oncology · 2018 · 19 citations

Innate Immune System, Immune Regulation, Immunology +26

Selected GRIN2A mutations in melanoma cause oncogenic effects that can be modulated by extracellular glutamate

Stacey Ann N. D’mello, Wayne R. Joseph, Taryn N. Green et al. · Cell Calcium · 2016 · 12 citations

Signal Transduction, Oncogenic Agent, Grin2a Mutations +8